Stockscreener 앱 받기
58.03
1.68%
0.96
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Disc Medicine Reports Q2 2025 Financial Results and Clinical Progress - TipRanks
Disc Medicine (IRON) Q2 Loss Widens 109% - AOL.com
Disc Medicine: Strong Financial Position and Promising Drug Pipeline Justify Buy Rating - TipRanks
Disc Medicine Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Disc Medicine Misses On Losses But Keeps Wall Street Optimistic - Finimize
Disc Medicine Stumbles On Earnings But Analysts Stay Bullish - Finimize
Disc Medicine (IRON) Q2 Loss Widens 109% - The Motley Fool
Disc Medicine Shares Fall After Wider-Than-Expected Q2 Loss - MarketScreener
Disc Medicine reports Q2 EPS ($1.58), consensus ($1.14) - TipRanks
Disc Medicine, Inc. SEC 10-Q Report - TradingView
Disc Medicine Earnings: FDA Filing Timeline Set for EPP Drug as Cash Reserves Hit $650M Milestone - Stock Titan
How strong is Disc Medicine Inc. company’s balance sheetInvest confidently with real-time market updates - Jammu Links News
Is Disc Medicine Inc. a good long term investmentDiscover dynamic stocks ready to soar - Jammu Links News
Is it the right time to buy Disc Medicine Inc. stockMarket-leading growth rates - Jammu Links News
What catalysts could drive Disc Medicine Inc. stock higher in 2025Achieve consistent double-digit growth - Jammu Links News
What analysts say about Disc Medicine Inc. stockMaximize portfolio growth with professional advice - Jammu Links News
Is Disc Medicine Inc. a growth stock or a value stockMarket-beating performance - Jammu Links News
Published on: 2025-08-03 11:24:58 - Jammu Links News
What are analysts’ price targets for Disc Medicine Inc. in the next 12 monthsBuild a winning investment strategy today - Jammu Links News
How many analysts rate Disc Medicine Inc. as a “Buy”Realize exceptional returns through smart trading - Jammu Links News
How does Disc Medicine Inc. generate profit in a changing economyHigh-octane investment opportunities await - Jammu Links News
Insider Selling at Disc Medicine Inc.: A Signal or a Symptom? - AInvest
Is Disc Medicine Inc. stock overvalued or undervaluedLow Risk Report For Consistent Profits - Jammu Links News
Institutional Investors in Disc Medicine, Inc. (NASDAQ:IRON) See US$140m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them. - 富途牛牛
Why Disc Medicine Inc. stock attracts strong analyst attentionNews Based Entry Opportunity Alerts Detected - metal.it
Morgan Stanley Assumes Coverage of Disc Medicine (IRON) With $85 PT - MSN
How does Disc Medicine Inc. compare to its industry peersExpert Picks Watchlist For 2025 - Jammu Links News
Disc Medicine's NDA Submission for Bitopertin in EPP: A High-Probability Catalyst for Value Creation - AInvest
Disc Medicine, Inc. (IRON) Set to Submit NDA for Bitopertin in October 2025 - Insider Monkey
What is the dividend policy of Disc Medicine Inc. stockMaximize gains with strategic stock entries - Jammu Links News
Are Investors Undervaluing Disc Medicine, Inc. (NASDAQ:IRON) By 49%? - Yahoo Finance
How volatile is Disc Medicine Inc. stock compared to the marketBreakneck growth rates - jammulinksnews.com
Published on: 2025-07-28 05:56:42 - Jammu Links News
Should I hold or sell Disc Medicine Inc. stock in 2025Invest smarter with real-time trading signals - Jammu Links News
When is the best time to buy Disc Medicine Inc. stockWatchlist Winner Update - metal.it
Is Disc Medicine Inc. stock a growth or value play2x Return Forecast - metal.it
Insider Selling at Disc Medicine Inc.: A Balancing Act Between Portfolio Strategy and Investor Sentiment - AInvest
Can Disc Medicine Inc. stock recover from recent declineSuperior profit margins - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):